Clinical Trials List
Protocol Number110390 (Zoster-006)
2010-06-15 - 2014-12-31
Phase III
Terminated3
-
Trial Applicant
GlaxoSmithKline
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- PAN-CHYR YANG Division of General Internal Medicine
- Ming-Shiang Wu Division of General Internal Medicine
- 陳宜君 Division of General Internal Medicine
- Chong-Jen Yu Division of General Internal Medicine
- 嚴崇仁 Division of General Internal Medicine
- Yee-Chun Chen Division of General Internal Medicine
- Kuo-Chin Huang Division of Family Medicine
- Szu-Min Hsieh Division of General Internal Medicine
- 陳人豪 Division of Geriatrics
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 賴秀昀 Division of Family Medicine
- 林明慧 Division of Family Medicine
- 陳德禮 Division of Infectious Disease
- 劉瑞瑤 Division of Family Medicine
- 吳彬源 Division of Family Medicine
- Yu-Jiun Chan Division of Infectious Disease
- Tzeng-Ji Chen Division of Family Medicine
- 林宜璁 Division of Family Medicine
- 馮長風 Division of Infectious Disease
- 林明憲 Division of Family Medicine
- 葉恆良 Division of Family Medicine
- Fu-Der Wang Division of Infectious Disease
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Te-Chun Hsia Division of Hematology & Oncology
- Pei-Ying Pai Division of Cardiovascular Diseases
- Ching-Chu Chen Division of Endocrinology
- Hsueh-Chou Lai Digestive System Department
- Chwen-Tzuei Chang Division of Endocrinology
- Cheng-Chieh Lin Division of Family Medicine
- Chung-Hsiang Liu Division of Neurology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
1310 participants
-
Global
15980 participants
